EP3202409A4 - Composition, structure cellulaire, kit de transplantation d'îlot, agent thérapeutique de transplantation de cellule d'îlot de langerhans, et agent de réduction de glycémie, composition comprenant des îlots, kit comprenant des îlots, et agent thérapeutique de transplantation d'îlot, et agent de réduction de glycémie - Google Patents
Composition, structure cellulaire, kit de transplantation d'îlot, agent thérapeutique de transplantation de cellule d'îlot de langerhans, et agent de réduction de glycémie, composition comprenant des îlots, kit comprenant des îlots, et agent thérapeutique de transplantation d'îlot, et agent de réduction de glycémie Download PDFInfo
- Publication number
- EP3202409A4 EP3202409A4 EP15846323.2A EP15846323A EP3202409A4 EP 3202409 A4 EP3202409 A4 EP 3202409A4 EP 15846323 A EP15846323 A EP 15846323A EP 3202409 A4 EP3202409 A4 EP 3202409A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- islet
- blood sugar
- transplant
- kit
- sugar reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/022—Artificial gland structures using bioreactors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/222—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2535/00—Supports or coatings for cell culture characterised by topography
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2537/00—Supports and/or coatings for cell culture characterised by physical or chemical treatment
- C12N2537/10—Cross-linking
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Botany (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Dispersion Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014200220 | 2014-09-30 | ||
JP2014262637 | 2014-12-25 | ||
JP2014262662 | 2014-12-25 | ||
JP2015030398 | 2015-02-19 | ||
PCT/JP2015/077516 WO2016052504A1 (fr) | 2014-09-30 | 2015-09-29 | Composition, structure cellulaire, kit de transplantation d'îlot, agent thérapeutique de transplantation de cellule d'îlot de langerhans, et agent de réduction de glycémie, composition comprenant des îlots, kit comprenant des îlots, et agent thérapeutique de transplantation d'îlot, et agent de réduction de glycémie |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3202409A1 EP3202409A1 (fr) | 2017-08-09 |
EP3202409A4 true EP3202409A4 (fr) | 2017-11-22 |
Family
ID=55630531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15846323.2A Pending EP3202409A4 (fr) | 2014-09-30 | 2015-09-29 | Composition, structure cellulaire, kit de transplantation d'îlot, agent thérapeutique de transplantation de cellule d'îlot de langerhans, et agent de réduction de glycémie, composition comprenant des îlots, kit comprenant des îlots, et agent thérapeutique de transplantation d'îlot, et agent de réduction de glycémie |
Country Status (4)
Country | Link |
---|---|
US (1) | US10335514B2 (fr) |
EP (1) | EP3202409A4 (fr) |
JP (2) | JP6466464B2 (fr) |
WO (1) | WO2016052504A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107921173B (zh) * | 2015-08-03 | 2021-07-06 | 富士胶片株式会社 | 细胞结构体、非人模型动物、非人模型动物的制造方法及被检验物质的评价方法 |
WO2018170394A1 (fr) * | 2017-03-17 | 2018-09-20 | Rutgers, The State University Of New Jersey | Compositions et méthodes pour la cicatrisation d'une blessure |
JP6903295B2 (ja) * | 2017-06-30 | 2021-07-14 | 富士フイルム株式会社 | ライソゾーム病処置剤 |
CN111344393A (zh) * | 2017-11-10 | 2020-06-26 | 富士胶片株式会社 | 从间充质干细胞制造胰岛素产生细胞的方法、胰岛素产生细胞、细胞构建体及医药组合物 |
JP2020062009A (ja) * | 2018-10-16 | 2020-04-23 | 東ソー株式会社 | 細胞培養基材、細胞培養基材の製造方法、及びスフェロイドの製造方法 |
JP2020081316A (ja) * | 2018-11-22 | 2020-06-04 | 株式会社日立製作所 | 細胞デバイス、細胞デバイスの製造方法及び細胞デバイスの移植方法 |
WO2020138028A1 (fr) * | 2018-12-25 | 2020-07-02 | 富士フイルム株式会社 | Kit de transplantation de cellule, procédé de fabrication d'une structure de type poche, et agent thérapeutique pour le diabète |
EP4019025A4 (fr) * | 2019-08-23 | 2022-11-30 | FUJIFILM Corporation | Composition comprenant une microcapsule et une structure cellulaire |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2601996A1 (fr) * | 2010-08-03 | 2013-06-12 | Hoya Corporation | Instrument thérapeutique et fixation de celui-ci |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130005279A (ko) | 2010-03-01 | 2013-01-15 | 후지필름 가부시키가이샤 | 생체 친화성을 갖는 고분자 블록과 세포로 이루어지는 세포 구조체 |
JP5579270B2 (ja) | 2010-08-06 | 2014-08-27 | 国立大学法人大阪大学 | 膵島と脂肪組織由来幹細胞を利用した膵島移植 |
JP5876787B2 (ja) | 2011-08-31 | 2016-03-02 | 富士フイルム株式会社 | 細胞移植用細胞構造体および細胞移植用細胞集合体 |
-
2015
- 2015-09-29 EP EP15846323.2A patent/EP3202409A4/fr active Pending
- 2015-09-29 JP JP2016552062A patent/JP6466464B2/ja active Active
- 2015-09-29 WO PCT/JP2015/077516 patent/WO2016052504A1/fr active Application Filing
-
2017
- 2017-03-29 US US15/472,855 patent/US10335514B2/en active Active
-
2019
- 2019-01-09 JP JP2019001734A patent/JP6714736B2/ja active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2601996A1 (fr) * | 2010-08-03 | 2013-06-12 | Hoya Corporation | Instrument thérapeutique et fixation de celui-ci |
Non-Patent Citations (3)
Title |
---|
BRETZEL R G ET AL: "Pancreatic islet and stem cell transplantation: new strategies in cell therapy of diabetes mellitus", PANMINERVA MEDICA, vol. 46, no. 1, March 2004 (2004-03-01), pages 25 - 42, XP009194526, ISSN: 0031-0808 * |
See also references of WO2016052504A1 * |
TASNEEM BHAIJI ET AL: "Improving cellular function and immune protection via layer-by-layer nanocoating of pancreatic islet [beta]-cell spheroids cocultured with mesenchymal stem cells", JOURNAL OF BIOMEDICAL MATERIALS RESEARCH. PART A, vol. 100A, no. 6, 1 June 2012 (2012-06-01), HOBOKEN, NY, US, pages 1628 - 1636, XP055370989, ISSN: 1549-3296, DOI: 10.1002/jbm.a.34111 * |
Also Published As
Publication number | Publication date |
---|---|
EP3202409A1 (fr) | 2017-08-09 |
JP6466464B2 (ja) | 2019-02-06 |
WO2016052504A1 (fr) | 2016-04-07 |
US10335514B2 (en) | 2019-07-02 |
JP2019056009A (ja) | 2019-04-11 |
JPWO2016052504A1 (ja) | 2017-07-06 |
US20170203005A1 (en) | 2017-07-20 |
JP6714736B2 (ja) | 2020-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2021221859A1 (en) | Universal donor stem cells and related methods | |
EP3202409A4 (fr) | Composition, structure cellulaire, kit de transplantation d'îlot, agent thérapeutique de transplantation de cellule d'îlot de langerhans, et agent de réduction de glycémie, composition comprenant des îlots, kit comprenant des îlots, et agent thérapeutique de transplantation d'îlot, et agent de réduction de glycémie | |
EP3167046A4 (fr) | Production et cryopréservation de cellules fucosylées à usage thérapeutique | |
EP3313404A4 (fr) | Compositions thérapeutiques, associations et procédés d'utilisation | |
EP3393536A4 (fr) | Membrane placentaire décellularisée et ses procédés de préparation et d'utilisation | |
EP3334820A4 (fr) | Cellules souches pluripotentes étendues et induites, procédés de fabrication et d'utilisation | |
HK1223628A1 (zh) | β- 新的 -酮- β-烷基膽烷酸衍生物在製備奧貝膽酸以及其在醫藥領域的用途 | |
EP3285877A4 (fr) | Préparations thérapeutiques à base de cellules apoptotiques sanguines regroupées et leurs utilisations | |
EP3600350A4 (fr) | Échafaudage biologique comprenant des cellules thérapeutiques | |
EP3297641A4 (fr) | Procédés pour le stockage de sang total et compositions correspondantes | |
EP3347027A4 (fr) | Néo-îlots comprenant des cellules souches et d'îlot et traitement du diabète sucré avec ceux-ci | |
EP3139935A4 (fr) | Compositions placentaires thérapeutiques, procédés de fabrication et méthodes d'utilisation | |
EP3138399A4 (fr) | Composition pour une transplantation d'organe, de tissu, ou de cellules, trousse et procédé de transplantation | |
EP3105190A4 (fr) | Traitement de rétrodiffusion de matrice d'aquifère | |
EP3102291A4 (fr) | Progranuline (pgrn) et ses dérivés pour le diagnostic et le traitement de maladies lysosomales | |
EP3242707A4 (fr) | Méthodes et dispositifs visant à prévenir les naissances prématurées | |
EP3238745A4 (fr) | Agent inducteur de mort cellulaire, agent cytostatique, et composition pharmaceutique pour le traitement de maladies provoquées par une croissance cellulaire anormale | |
EP3117839A4 (fr) | Composition pour induire la transdifférenciation directe de cellules somatiques en cellules progénitrices vasculaires, et son utilisation | |
EP3710021A4 (fr) | Compositions pour la fabrication de cellules d'ilôts et procédés d'utilisation | |
EP3247365A4 (fr) | Nouvelle composition iodophore et procédés d'utilisation | |
EP3157504A4 (fr) | Compositions stimulant les cellules souches et procédés | |
EP3299023A4 (fr) | Cellule souche mésenchymateuse cultivée en hypoxie et utilisation de celle-ci | |
EP3132024A4 (fr) | Cellules souches pluripotentes induites chimiquement pour applications thérapeutiques sûres | |
EP3071214A4 (fr) | Compositions à base de salacia, méthodes de traitement impliquant leur administration et leurs procédés de préparation | |
EP3645020A4 (fr) | Compositions et procédés pour la thérapie cellulaire adoptive |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20170329 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20171020 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 47/42 20170101ALI20171016BHEP Ipc: A61P 3/10 20060101ALI20171016BHEP Ipc: A61K 35/39 20150101ALI20171016BHEP Ipc: A61L 27/00 20060101ALI20171016BHEP Ipc: A61K 9/16 20060101ALI20171016BHEP Ipc: A61K 35/12 20150101AFI20171016BHEP |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20190516 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: FUJIFILM CORPORATION |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |